Forbion Capital Fund IV Cooperatief U.A.'s Form 4 filing
NewAmsterdam Pharma Co N.V.NAMS · filed Dec 26, 2024
- Accession no.
- 0000950170-24-140408
- Filed
- Dec 26, 2024, 4:15 PM ET
- Trade date
- Dec 20-24, 2024
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $2.33M. It was filed 6 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Forbion Capital Fund IV Cooperatief U.A.CIK 0001823747 | 10% Owner |
| Forbion Growth Opportunities Fund I Cooperatief U.A.CIK 0001911047 | 10% Owner |
| Forbion Growth Management B.V.CIK 0001918318 | 10% Owner |
| Forbion IV Management B.V.CIK 0002005384 | 10% Owner |
| ForGrowth NAP B.V.CIK 0002005407 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2024 | Ordinary Shares | SSaleDisposed | −44,143 | $25.53F2,F3 | −$1,126,992.86 | 10,807,853 | Indirect | |
| Dec 20, 2024 | Ordinary Shares | SSaleDisposed | −5,629 | $26.13F5 | −$147,071.13 | 10,802,224 | Indirect | |
| Dec 23, 2024 | Ordinary Shares | SSaleDisposed | −25,132 | $25.49F6 | −$640,624.73 | 10,777,092 | Indirect | |
| Dec 24, 2024 | Ordinary Shares | SSaleDisposed | −16,164 | $25.66F7 | −$414,831.28 | 10,760,928 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents 19,388 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 24,755 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.99. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,807,853 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,155,680 are held by PoolCo and are allocated to ForGrowth,
Referenced by the price of 1 transaction in Table I.
- F3
(Continued from footnote 2) of which 4,094,330 shares are beneficially owned by Forbion Growth I and 6,061,350 shares are beneficially owned by Forbion IV.
Referenced by the price of 1 transaction in Table I.
- F5
Represents 2,472 shares sold on behalf of Forbion Growth I and 3,157 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.02 to $26.205. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,802,224 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,150,051 are held by PoolCo and are allocated to ForGrowth, of which 4,091,858 shares are beneficially owned by Forbion Growth I and 6,058,193 shares are beneficially owned by Forbion IV.
Referenced by the price of 1 transaction in Table I.
- F6
Represents 11,038 shares sold on behalf of Forbion Growth I and 14,094 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.835. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,777,092 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,124,919 are held by PoolCo and are allocated to ForGrowth, of which 4,080,820 shares are beneficially owned by Forbion Growth I and 6,044,099 shares are beneficially owned by Forbion IV.
Referenced by the price of 1 transaction in Table I.
- F7
Represents 7,099 shares sold on behalf of Forbion Growth I and 9,065 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.23 to $26.00. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,760,928 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,108,755 are held by PoolCo and are allocated to ForGrowth, of which 4,073,721 shares are beneficially owned by Forbion Growth I and 6,035,034 shares are beneficially owned by Forbion IV.
Referenced by the price of 1 transaction in Table I.